Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012256 |
---|---|
Receipt number | R000014329 |
Scientific Title | Pase II study of neoadjuvant chemotherapy with Docetaxel, Carboplatin, and Trastuzumab for operable Her2-positive breast cancer patients. |
Date of disclosure of the study information | 2013/11/09 |
Last modified on | 2018/05/28 17:25:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/11/09 16:19:16 | ||
2 | Update | 2018/05/28 17:25:48 | Recruitment status |